Context:

The Ulia Pharma project aims to develop the first compact, automatic and economical machine for the decentralized production of pills with a customized active ingredient. The UP design, patented in Italy and patent pending in the EU and the US, aims to create a new pharmaceutical manufacturing technology by mixing traditional industrial machinery (Coating Pan) with the flexibility of 3dprinters

The challenge:

• The system must work at low temperatures.
• Use biocompatible materials.
• Precisely control the dosages.
• Pharmaceutical 3d printing is the solution to a wide range of problems such as overdoses, scarcity or waste of drugs, difficulties in using intravenous treatments.

Supplier:

UliaPharma